109 results
8-K
EX-10.1
LEXX
Lexaria Bioscience Corp
16 Feb 24
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:30pm
and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface … or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing
8-K
EX-99.1
LEXX
Lexaria Bioscience Corp
24 Jan 24
Regulation FD Disclosure
2:12pm
in a losing position. Combined with the regional banking crisis in the spring of 2023, that did not foster a positive environment for raising capital
8-K
EX-10.1
w432ku
3 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-1.1
mhespx 8u5
12 Aug 22
Entry into a Material Definitive Agreement
5:19pm
424B3
3ej9hzehzwog
28 Dec 21
Prospectus supplement
4:06pm
424B3
cbhxkflpw1q2
28 Dec 21
Prospectus supplement
4:05pm
POS AM
3a7q2b37b1s
17 Dec 21
Prospectus update (post-effective amendment)
5:20pm
POS AM
4mr5eyhgz2fwc
17 Dec 21
Prospectus update (post-effective amendment)
5:04pm
8-K
EX-99.1
8nkg9g
8 Sep 21
Lexaria’s Human Clinical Study Delivers Effective and Safe Blood Pressure Reduction Results over 24-hour Ambulatory Period
4:46pm
8-K
EX-99.2
ijp g4plp
8 Sep 21
Lexaria’s Human Clinical Study Delivers Effective and Safe Blood Pressure Reduction Results over 24-hour Ambulatory Period
4:46pm
S-8
xpcynzm bdf5xatqgi
30 Jul 21
Registration of securities for employees
4:16pm
8-K
EX-99.1
co1y3ac82p6ciaoq1g
30 Jul 21
Other Events
1:07pm
424B3
jks6 l52j0
3 Mar 21
Prospectus supplement
5:01pm